Meet2Win
Thursday 11 May 2017
Bordeaux, France
Location
MATWIN organises the 3rd edition of the Oncolgy Business Convention. MATWIN is a national platform supporting innovation in oncology. The programme is based on a public/private partnership between pharma companies (Amgen, AstraZeneca, BMS, Celgene, GSK, Janssen, Novartis, Pfizer, Pierre Fabre, Roche, Sanofi), UNICANCER and the Canceropôles.
The MEET2WIN convention is organised around face-to-face meetings and is bringing together all parties involved in oncology innovation. MEET2WIN offers the opportunity to meet representatives of big pharma & diagnostic companies, biotechs, startups, researchers, clinicians, TTO’s, investors etc. to boost collaborations opportunities. MEET2WIN is supported by Enterprise Europe Network.
| Deadlines | Tasks |
|---|---|
| 5 May 2017 | Registration and profile submission |
| 6 Apr – 5 May 2017 | Online selection of bilateral meetings |
| 11-12 May 2017 | Bilateral meetings |
| Contact person in Switzerland | This email address is being protected from spambots. You need JavaScript enabled to view it. +41 (0)31 380 60 28 |
|---|---|
| Participant list | Search Online |
| Website | www.b2match.eu/meet2win2017 |
| Event language | English |
| Participant fee | Company (pharma/diagnostics companies, biotechs, CRO, funding structures...) 350 EUR. TTO/cluster/association 300 EUR. Emerging company (*Start-up ≤ 5 years, ≤ 10 employees) 250 EUR. Academic 100 EUR, Student 75 EUR. |
How it works
- Register and submit your cooperation profile online (be aware of the deadline)
- Profiles are published in a constantly updated online catalogue
- Select interesting profiles and request meetings
- Individual meeting times will be sent